Vandetanib reduces inflammatory cytokines and ameliorates COVID-19 in infected mice (2021)
- Authors:
- Puhl, Ana C.
- Gomes, Giovanni Freitas
- Damasceno, Samara
- Fritch, Ethan J.
- Levi, James A.
- Johnson, Nicole J.
- Scholle, Frank
- Premkumar, Lakshmanane
- Hurst, Brett L.
- LeeMontiel, Felipe
- Veras, Flávio Protásio
- Batah, Sabrina Setembre
- Fabro, Alexandre Todorovic
- Moorman, Nathaniel J.
- Yount, Boyd L.
- Dickmander, Rebekah
- Baric, Ralph
- Pearce, Kenneth H.
- Cunha, Fernando de Queiroz
- Alves Filho, José Carlos Farias
- Cunha, Thiago Mattar
- Ekins, Sean
- USP affiliated authors: VERAS, FLÁVIO PROTÁSIO - FCFRP ; FABRO, ALEXANDRE TODOROVIC - FMRP ; CUNHA, FERNANDO DE QUEIROZ - FMRP ; ALVES FILHO, JOSÉ CARLOS FARIAS - FMRP ; CUNHA, THIAGO MATTAR - FMRP ; GOMES, GIOVANNI FREITAS - FMRP ; DAMASCENO, SAMARA - FMRP ; BATAH, SABRINA SETEMBRE - FMRP
- Unidades: FCFRP; FMRP
- DOI: 10.1101/2021.12.16.472155
- Subjects: ANTIVIRAIS; ANTINEOPLÁSICOS; CITOCINAS; COVID-19
- Keywords: Antiviral; SARS-CoV-2; Spike protein; Entrectinib; Vandetanib
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
- Licença: other-oa
-
ABNT
PUHL, Ana C. et al. Vandetanib reduces inflammatory cytokines and ameliorates COVID-19 in infected mice. bioRxiv, p. 1-52, 2021Tradução . . Disponível em: https://doi.org/10.1101/2021.12.16.472155. Acesso em: 27 dez. 2025. -
APA
Puhl, A. C., Gomes, G. F., Damasceno, S., Fritch, E. J., Levi, J. A., Johnson, N. J., et al. (2021). Vandetanib reduces inflammatory cytokines and ameliorates COVID-19 in infected mice. bioRxiv, 1-52. doi:10.1101/2021.12.16.472155 -
NLM
Puhl AC, Gomes GF, Damasceno S, Fritch EJ, Levi JA, Johnson NJ, Scholle F, Premkumar L, Hurst BL, LeeMontiel F, Veras FP, Batah SS, Fabro AT, Moorman NJ, Yount BL, Dickmander R, Baric R, Pearce KH, Cunha F de Q, Alves Filho JCF, Cunha TM, Ekins S. Vandetanib reduces inflammatory cytokines and ameliorates COVID-19 in infected mice [Internet]. bioRxiv. 2021 ; 1-52.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1101/2021.12.16.472155 -
Vancouver
Puhl AC, Gomes GF, Damasceno S, Fritch EJ, Levi JA, Johnson NJ, Scholle F, Premkumar L, Hurst BL, LeeMontiel F, Veras FP, Batah SS, Fabro AT, Moorman NJ, Yount BL, Dickmander R, Baric R, Pearce KH, Cunha F de Q, Alves Filho JCF, Cunha TM, Ekins S. Vandetanib reduces inflammatory cytokines and ameliorates COVID-19 in infected mice [Internet]. bioRxiv. 2021 ; 1-52.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1101/2021.12.16.472155 - Vandetanib blocks the cytokine storm in SARS-CoV-2-infected mice
- Pyronaridine protects against SARS-CoV-2 infection in mouse
- Toll-like receptor 9 activation in neutrophils impairs chemotaxis and reduces sepsis outcome
- Superoxide anion-induced pain and inflammation depends on TNFα/TNFR1 signaling in mice
- The citrus flavanone naringenin reduces gout-induced joint pain and inflammation in mice by inhibiting the activation of NFκB and macrophage release of IL-1β
- Trans-chalcone attenuates pain and inflammation in experimental acute gout arthritis in mice
- Hesperidin methylchalcone suppresses experimental gout arthritis in mice by inhibiting NF-KB activation
- Differential regulation of oxidative stress and cytokine production by endothelin ETA and ETB receptors in superoxide anion-induced inflammation and pain in mice
- Bosentan, a mixed endothelin receptor antagonist, inhibits superoxide anion-induced pain and inflammation in mice
- Curcumin inhibits superoxide anion-induced pain-like behavior and leukocyte recruitment by increasing Nrf2 expression and reducing NF-kB activation
Informações sobre o DOI: 10.1101/2021.12.16.472155 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
